Alkermes plc (NASDAQ:ALKS) Q1 2022 Earnings Conference Call April 27, 2022 8:00 AM ET
Company Participants
Sandra Coombs - SVP, IR & Corporate Affairs
Iain Brown - CFO
Todd Nichols - CCO
Richard Pops - CEO
Conference Call Participants
Chris Shibutani - Goldman Sachs
Vamil Divan - Mizuho
Brandon Folkes - Cantor Fitzgerald
Amy Li - Jefferies
Umer Raffat - Evercore
Cory Kasimov - JPMorgan
Paul Matteis - Stifel
Marc Goodman - SVB Leerink
Jason Gerberry - Bank of America
Operator
Greetings, and welcome to the Alkermes First Quarter 2022 Financial Results Conference Call. My name is Rob, and I will be your operator for today's call. [Operator Instructions]. Please note this conference is being recorded.
At this time, I will now turn the call over to Sandra Coombs, Senior Vice President, Investor Relations and Corporate Affairs. Sandy, you may now begin.
Sandra Coombs
Thank you. Good morning. Welcome to the Alkermes Plc's conference call to discuss our financial results and business update for the quarter ended March 31, 2022.
With me today are Richard Pops, our CEO; Iain Brown, our CFO, and Todd Nichols, our Chief Commercial Officer.
Before we begin, I encourage everyone to go to the Investors section of alkermes.com to find our press release, related financial tables, and reconciliations of the GAAP to non-GAAP financial measures that we'll discuss today.
We believe the non-GAAP financial results in conjunction with the GAAP results are useful in understanding the ongoing economics of our business.
Our discussions during this conference call will include forward-looking statements. Actual results could differ materially from these forward-looking statements. Please see Slide 2 of the accompanying presentation, our press release issued this morning and our most recent annual and quarterly report filed with the SEC for important Risk Factors that could cause our actual results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise the information provided on this call or in the accompanying presentation as a result of new information or future results or developments. After our prepared remarks, we'll open the call for Q&A.
And I'll turn the call over to Iain.
Iain Brown
Great. Thank you, Sandy, and hello everyone.
I'm pleased to report our first quarter 2022 results that demonstrate ongoing momentum across the company, the strength of our proprietary commercial product portfolio, our continued focus on operating efficiency, and the commercial leverage we have built into the business that's becoming more evidence with the launch of LYBALVI.